Norges Bank’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-660,690
| Closed | -$8.99M | – | 2140 |
|
|
2022
Q1 | $8.99M | Hold |
660,690
| – | – | ﹤0.01% | 1742 |
|
|
2021
Q4 | $13M | Buy |
660,690
+331,347
| +101% | +$6.52M | ﹤0.01% | 1662 |
|
|
2021
Q3 | $10.6M | Hold |
329,343
| – | – | ﹤0.01% | 1747 |
|
|
2021
Q2 | $11.1M | Hold |
329,343
| – | – | ﹤0.01% | 1749 |
|
|
2021
Q1 | $12.4M | Hold |
329,343
| – | – | ﹤0.01% | 1729 |
|
|
2020
Q4 | $10.9M | Buy |
329,343
+70,000
| +27% | +$2.33M | ﹤0.01% | 1751 |
|
|
2020
Q3 | $9.51M | Hold |
259,343
| – | – | ﹤0.01% | 1729 |
|
|
2020
Q2 | $8.54M | Hold |
259,343
| – | – | ﹤0.01% | 1760 |
|
|
2020
Q1 | $6.7M | Sell |
259,343
-57,957
| -18% | -$1.5M | ﹤0.01% | 1750 |
|
|
2019
Q4 | $9.88M | Buy |
+317,300
| New | +$9.88M | ﹤0.01% | 1804 |
|